Advertisement

Hepatobiliary Diseases in the Cancer Patient Leading to Critical Illness

  • Faisal S. Ali
  • Hamzah Abu-Sbeih
  • Emmanuel Coronel
  • Yinghong WangEmail author
Living reference work entry

Abstract

Cancer patients represent a special subset of population prone to a plethora of adverse effects, secondary to cancer or cancer therapy. Among the most notable adverse effects are those which cause insult to the hepatobiliary system. This subset of adverse effects is particularly concerning as it can delay lifesaving cancer therapy. Interestingly, such lifesaving cancer therapy often is the culprit of hepatobiliary disease among cancer patients. Exceptions to this generalization are hepatic and pancreatobiliary malignancies leading to malignant biliary obstruction, hepatic tumor rupture, or liver failure. Cancer metastases affecting the hepatobiliary system can produce a similar picture. Often such hepatobiliary disease can be difficult to manage and necessitate, at least in part, management in the intensive care (ICU) unit. However, there are no well-defined pathways for optimal ICU care for this patient population and represent a major knowledge gap that requires to be filled urgently. This chapter deals with hepatobiliary disease that is commonly encountered in cancer patients and may necessitate intensive management.

Keywords

Acute liver failure Cancer Intensive care unit Cholangitis Malignant biliary obstruction Hepatic tumor rupture Chemotherapy Hepatic encephalopathy Variceal hemorrhage Hepatic abscess Infection Survival 

References

  1. 1.
    Abboud PA, et al. Predictors of common bile duct stones prior to cholecystectomy: a meta-analysis. Gastrointest Endosc. 1996;44(4):450–5. http://www.ncbi.nlm.nih.gov/pubmed/8905367. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  2. 2.
    Acharya SK, et al. Efficacy of l-Ornithine l-Aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136(7):2159–68. http://www.ncbi.nlm.nih.gov/pubmed/19505424. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  3. 3.
    Alba L, et al. Lactulose therapy in acute liver failure. J Hepatol. 2002;36:33. http://linkinghub.elsevier.com/retrieve/pii/S0168827802800976. Accessed 25 Aug 2018.CrossRefGoogle Scholar
  4. 4.
    Alkofer B, et al. Are pyogenic liver abscesses still a surgical concern? A Western experience. HPB Surg. 2012;2012:1–7. http://www.ncbi.nlm.nih.gov/pubmed/22536008. Accessed Sept 18, 2018.CrossRefGoogle Scholar
  5. 5.
    Benten D, et al. Low recurrence of preexisting extrahepatic malignancies after liver transplantation. Liver Transpl. 2008;14(6):789–98. http://www.ncbi.nlm.nih.gov/pubmed/18412260. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  6. 6.
    von Bergwelt-Baildon M, et al. CCC meets ICU: redefining the role of critical care of cancer patients. BMC Cancer. 2010;10(1):612. http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-612. Accessed 21 Aug 2018.CrossRefGoogle Scholar
  7. 7.
    Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure – a controlled clinical trial. J Hepatol. 2004;41(1):89–96. http://www.ncbi.nlm.nih.gov/pubmed/15246213. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  8. 8.
    Biskup E, Yang X-Y. Pyogenic hepatic abscess – less is more a review for general internists. Praxis. 2015;104(20):1091–5. https://econtent.hogrefe.com/doi/10.1024/1661-8157/a002155. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  9. 9.
    Cai Y-L, et al. Percutaneous needle aspiration versus catheter drainage in the management of liver abscess: a systematic review and meta-analysis. HPB. 2015;17(3):195–201. http://www.ncbi.nlm.nih.gov/pubmed/25209740. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  10. 10.
    Carstensen H, et al. Hepatosplenic candidiasis in children with cancer. Three cases in leukemic children and a literature review. Pediatr Hematol Oncol. 1990;7(1):3–12. http://www.ncbi.nlm.nih.gov/pubmed/2204407. Accessed 17 Sept 2018.PubMedCrossRefGoogle Scholar
  11. 11.
    Chait Y, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol. 2005;129(4):553–60. http://www.ncbi.nlm.nih.gov/pubmed/15877740. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  12. 12.
    Chen C-H, et al. Initial presentations and final outcomes of primary pyogenic liver abscess: a cross-sectional study. BMC Gastroenterol. 2014;14(1):133. http://www.ncbi.nlm.nih.gov/pubmed/25066384. Accessed 18 Sept 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Clemmesen JO, et al. Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration. Hepatology. 1999;29(3): 648–53. http://www.ncbi.nlm.nih.gov/pubmed/10051463. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  14. 14.
    D’Amico G, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10): 1180–93. http://www.ncbi.nlm.nih.gov/pubmed/24654740. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  15. 15.
    Doyle HR, et al. Adult respiratory distress syndrome secondary to end-stage liver disease-successful outcome following liver transplantation. Transplantation. 1993;55(2):292–6. http://www.ncbi.nlm.nih.gov/pubmed/8434378. Accessed 31 Aug 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Durward QJ, et al. Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension. J Neurosurg. 1983;59(6):938–44. http://www.ncbi.nlm.nih.gov/pubmed/6631516. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  17. 17.
    Ferreira J, et al. Risk factors for noninvasive ventilation failure in cancer patients in the intensive care unit: a retrospective cohort study. Elsevier. n.d. https://www.sciencedirect.com/science/article/pii/S0883944115002683. Accessed 21 Aug 2018.
  18. 18.
    Forbes A, et al. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology (Baltimore, Md). 1989;10(3):306–10. http://www.ncbi.nlm.nih.gov/pubmed/2759548. Accessed 25 Aug 2018.CrossRefGoogle Scholar
  19. 19.
    Garcia-Tsao G, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38. http://www.ncbi.nlm.nih.gov/pubmed/17879356. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  20. 20.
    Gasco J, et al. State-of-the-art management and monitoring of brain edema and intracranial hypertension in fulminant hepatic failure. A proposed algorithm. Acta Neurochir Suppl. 2010;106:311–4. http://www.ncbi.nlm.nih.gov/pubmed/19812970. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  21. 21.
    Gates J, et al. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. 1. n.d. https://pubs.rsna.org/doi/pdf/10.1148/radiographics.19.2.g99mr08399. Accessed 19 Sept 2018.
  22. 22.
    Gelabert-González M, et al. The Camino intracranial pressure device in clinical practice. Assessment in a 1000 cases. Acta Neurochir. 2006;148(4):435–41. http://link.springer.com/10.1007/s00701-005-0683-3. Accessed 31 Aug 2018.PubMedCrossRefGoogle Scholar
  23. 23.
    Grigorian A, O’Brien CB. Hepatotoxicity secondary to chemotherapy. J Clin Transl Hepatol. 2014;2(2): 95–102. http://www.ncbi.nlm.nih.gov/pubmed/26357620. Accessed 26 Aug 2018.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Hall TC, et al. Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review. World J Surg. 2011;35(11):2510–20. http://www.ncbi.nlm.nih.gov/pubmed/21882035. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  25. 25.
    Hansen MM, et al. Fatal hepatitis following irradiation and vincristine. Acta Med Scand. 1982;212(3):171–4. http://www.ncbi.nlm.nih.gov/pubmed/7148508. Accessed 8 Sept 2018PubMedCrossRefGoogle Scholar
  26. 26.
    Harrison PM, et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet (London, England). 1990;335(8705):1572–3. http://www.ncbi.nlm.nih.gov/pubmed/1972496. Accessed 23 Aug 2018.CrossRefGoogle Scholar
  27. 27.
    Hollingshead M, et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol. 2005;16(5):651–61. http://www.ncbi.nlm.nih.gov/pubmed/15872320. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  28. 28.
    Hope WW, et al. Optimal treatment of hepatic abscess. Am Surg. 2008;74(2):178–82. http://www.ncbi.nlm.nih.gov/pubmed/18306874. Accessed 18 Sept 2018.PubMedGoogle Scholar
  29. 29.
    Iida H, et al. Risk of abscess formation after liver tumor radiofrequency ablation: a review of 8 cases with a history of enterobiliary anastomosis. Hepato-Gastroenterology. 2014;61(135):1867–70. http://www.ncbi.nlm.nih.gov/pubmed/25713880. Accessed 18 Sept 2018.PubMedGoogle Scholar
  30. 30.
    Jayakrishnan TT, et al. Management of acute cholecystitis in cancer patients: a comparative effectiveness approach. Surg Endosc. 2014;28(5):1505–14. http://link.springer.com/10.1007/s00464-013-3344-2. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  31. 31.
    Karvellas CJ, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12(11):1942–1949.e1. https://www.sciencedirect.com/science/article/pii/S154235651400439X. Accessed 10 Sept 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Khozouz RF, Huq SZ, Perry MC. Radiation-induced liver disease. J Clin Oncol. 2008;26(29):4844–5. http://ascopubs.org/doi/10.1200/JCO.2008.18.2931. Accessed 8 Sept 2018.PubMedCrossRefGoogle Scholar
  33. 33.
    Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001;345(23):1683–8. http://www.ncbi.nlm.nih.gov/pubmed/11759648. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  34. 34.
    Kumar D, et al. Faecolith migrating from the appendix to produce liver abscess after subhepatic laparoscopic appendectomy. Trop Dr. 2015;45(4):241–4. http://www.ncbi.nlm.nih.gov/pubmed/25824562. Accessed 18 Sept 2018.Google Scholar
  35. 35.
    Kun LE, Camitta BM. Hepatopathy following irradiation and adriamycin. Cancer. 1978;42(1):81–4. http://www.ncbi.nlm.nih.gov/pubmed/667811. Accessed 8 Sept 2018.PubMedCrossRefGoogle Scholar
  36. 36.
    Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med. 2002;347(1):43–53. http://www.ncbi.nlm.nih.gov/pubmed/12097540. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  37. 37.
    Lai ECH. Spontaneous rupture of hepatocellular carcinoma. Arch Surg. 2006;141(2):191. http://archsurg.jamanetwork.com/article.aspx?doi=10.1001/archsurg.141.2.191. Accessed 17 Sept 2018.PubMedCrossRefGoogle Scholar
  38. 38.
    Lang SA, et al. Clinical management of acute portal/mesenteric vein thrombosis. Viszeralmedizin. 2014;30(6):394–400. http://www.ncbi.nlm.nih.gov/pubmed/26285602. Accessed 26 Sept 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Lardière-Deguelte S, et al. Hepatic abscess: diagnosis and management. J Visc Surg. 2015;152(4):231–43. http://www.ncbi.nlm.nih.gov/pubmed/25770745. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  40. 40.
    Le TV, et al. Insertion of intracranial pressure monitors in fulminant hepatic failure patients. Neurosurgery. 2010;66(3):455–8. http://www.ncbi.nlm.nih.gov/pubmed/20173540. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  41. 41.
    Lee J, DaVee T. Biliary obstruction: endoscopic approaches. Semin Interv Radiol. 2017;34(04): 369–75. http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1608828. Accessed 18 Sept 2018.CrossRefGoogle Scholar
  42. 42.
    Lee WM, et al. Intravenous N-Acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137(3):856–864.e1. http://www.ncbi.nlm.nih.gov/pubmed/19524577. Accessed 23 Aug 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Lee WM, Larson AM, Todd Stravitz R. AASLD position paper: the management of acute liver failure: update 2011 Contents recommendations full text references forward (click section title or page number). 2011. https://www.aasld.org/sites/default/files/guideline_documents/alfenhanced.pdf. Accessed 10 Sept 2018.
  44. 44.
    Leung CS, et al. A retrospective review of transcatheter hepatic arterial embolisation for ruptured hepatocellular carcinoma. J R Coll Surg Edinb. 2002;47(5):685–8. http://www.ncbi.nlm.nih.gov/pubmed/12463708. Accessed 17 Sept 2018.PubMedGoogle Scholar
  45. 45.
    Levitsky J, et al. Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. Liver Transpl. 2008;14(10):1498–504. http://www.ncbi.nlm.nih.gov/pubmed/18825709. Accessed 10 Sept 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Lin Y-T, et al. Pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma. Am J Med. 2011;124(12):1158–64. http://www.ncbi.nlm.nih.gov/pubmed/22114829. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  47. 47.
    Liu C-L, et al. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol. 2001;19(17):3725–32. http://www.ncbi.nlm.nih.gov/pubmed/11533094. Accessed 17 Sept 2018.PubMedCrossRefGoogle Scholar
  48. 48.
    Lok ASF, McMahon BJ, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology. 2004;39(3):857–61. http://www.ncbi.nlm.nih.gov/pubmed/14999707. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  49. 49.
    Lübbert C, Wiegand J, Karlas T. Therapy of liver abscesses. Viszeralmedizin. 2014;30(5):3–3. http://www.ncbi.nlm.nih.gov/pubmed/26287275. Accessed 18 Sept 2018.CrossRefGoogle Scholar
  50. 50.
    Maor Y, Malnick S. Liver injury induced by anticancer chemotherapy and radiation therapy. Int J Hepatol. 2013;2013:815105. http://www.ncbi.nlm.nih.gov/pubmed/23970972. Accessed 26 Aug 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Matsukuma KE, et al. Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD). J Gastrointest Oncol. 2016;7(Suppl 1):S21–31. http://www.ncbi.nlm.nih.gov/pubmed/27034810. Accessed 10 Sept 2018.PubMedPubMedCentralGoogle Scholar
  52. 52.
    Matthews JB, et al. Hepatic abscess after biliary tract procedures. Surg Gynecol Obstet. 1990;170(6): 469–75. http://www.ncbi.nlm.nih.gov/pubmed/2111586. Accessed 18 Sept 2018.PubMedGoogle Scholar
  53. 53.
    Mavilia MG, Molina M, Wu GY. The evolving nature of hepatic abscess: a review. J Clin Transl Hepatol. 2016;4:158. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913073/pdf/JCTH-4-158.pdf. Accessed 18 Sept 2018.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Morgan C, et al. Management of uncommon chemotherapy-induced emergencies. Lancet Oncol. 2011;12(8):806–14. http://www.ncbi.nlm.nih.gov/pubmed/21276754. Accessed 19 Sept 2018.PubMedCrossRefGoogle Scholar
  55. 55.
    Mosler P. Diagnosis and management of acute cholangitis. Curr Gastroenterol Rep. 2011;13(2): 166–72. http://link.springer.com/10.1007/s11894-010-0171-7. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  56. 56.
    Muñoz SJ. Difficult management problems in fulminant hepatic failure. Semin Liver Dis. 1993;13(4): 395–413. http://www.ncbi.nlm.nih.gov/pubmed/8303321. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  57. 57.
    Murphy N, et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004;39(2):464–70. http://www.ncbi.nlm.nih.gov/pubmed/14767999. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  58. 58.
    Nath F, Galbraith S. The effect of mannitol on cerebral white matter water content. J Neurosurg. 1986;65(1): 41–3. http://www.ncbi.nlm.nih.gov/pubmed/3086519. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  59. 59.
    Ogren M, et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006;12(13):2115–9. http://www.ncbi.nlm.nih.gov/pubmed/16610067. Accessed 18 Sept 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Oh D, et al. EUS-guided cholecystostomy versus endoscopic transpapillary cholecystostomy for acute cholecystitis in high-risk surgical patients. Gastrointest Endosc. 2018. http://www.ncbi.nlm.nih.gov/pubmed/30213575. Accessed 23 Sept 2018.
  61. 61.
    Ostapowicz G, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–54. http://www.ncbi.nlm.nih.gov/pubmed/12484709. Accessed 23 Aug 2018.PubMedCrossRefGoogle Scholar
  62. 62.
    Pang TCY, et al. Pyogenic liver abscess: an audit of 10 years’ experience. World J Gastroenterol. 2011;17(12):1622–30. http://www.ncbi.nlm.nih.gov/pubmed/21472130. Accessed 18 Sept 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Rangnekar AS, et al. Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. Liver Transpl. 2013;19(9):991–1000. http://www.ncbi.nlm.nih.gov/pubmed/23780824. Accessed 26 Aug 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Rich NE, et al. Malignant infiltration of the liver presenting as acute liver failure. Clin Gastroenterol Hepatol. 2015;13(5):1025–8. http://www.ncbi.nlm.nih.gov/pubmed/25277846. Accessed 8 Sept 2018.PubMedCrossRefGoogle Scholar
  65. 65.
    Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg. 1995;83(6):949–62. http://www.ncbi.nlm.nih.gov/pubmed/7490638. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  66. 66.
    Schellongowski P, et al. Critically ill patients with cancer: chances and limitations of intensive care medicine – a narrative review. ESMO Open. 2016;1(5):e000018. http://esmoopen.bmj.com/lookup/doi/10.1136/esmoopen-2015-000018. Accessed 21 Aug 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Shin JU, et al. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma. Dig Liver Dis. 2014;46(9):813–7. http://www.ncbi.nlm.nih.gov/pubmed/24881853. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  68. 68.
    Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol-Gastrointest Liver Physiol. 1985;248(6):G618–25. http://www.ncbi.nlm.nih.gov/pubmed/4003545. Accessed 10 Sept 2018.CrossRefGoogle Scholar
  69. 69.
    Singal AK, Kamath PS, Tefferi A. Mesenteric venous thrombosis. Mayo Clin Proc. 2013;88(3):285–94. http://linkinghub.elsevier.com/retrieve/pii/S0025619613000694. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  70. 70.
    Singh A, et al. Diagnostic accuracy of MRCP as compared to ultrasound/CT in patients with obstructive jaundice. J Clin Diagn Res. 2014;8(3):103–7. http://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2014&volume=8&issue=3&page=103&issn=0973-709x&id=4120. Accessed 18 Sept 2018.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Solomkin JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133–64. https://academic.oup.com/cid/article-lookup/doi/10.1086/649554. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  72. 72.
    Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6(9): 542–53. http://www.ncbi.nlm.nih.gov/pubmed/19652652. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  73. 73.
    Stravitz RT, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56(1):129–36. http://www.ncbi.nlm.nih.gov/pubmed/21703173. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  74. 74.
    Thomsen RW, et al. Risk of cholecystitis in patients with cancer. Cancer. 2008;113(12):3410–9. http://www.ncbi.nlm.nih.gov/pubmed/18951518. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  75. 75.
    Trump DL, et al. Anaerobic liver abscess and intrahepatic metastases. A case report and review of the literature. Cancer. 1978;41(2):682–6. http://doi.wiley.com/10.1002/1097-0142%28197802%2941%3A2%3C682%3A%3AAID-CNCR2820410237%3E3.0.CO%3B2-I. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  76. 76.
    Vergara V, et al. Spontaneous rupture of hepatocelluar carcinoma: surgical resection and long-term survival. Eur J Surg Oncol (EJSO). 2000;26(8):770–2. http://www.ncbi.nlm.nih.gov/pubmed/11087643. Accessed 17 Sept 2018.CrossRefGoogle Scholar
  77. 77.
    Weitz J, et al. Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma. Surgery. 2004;135(3):273–81. http://www.ncbi.nlm.nih.gov/pubmed/14976477. Accessed 17 Sept 2018.PubMedCrossRefGoogle Scholar
  78. 78.
    Wells M, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35(11):1267–78. http://www.ncbi.nlm.nih.gov/pubmed/22486630. Accessed 10 Sept 2018.PubMedCrossRefGoogle Scholar
  79. 79.
    Wijdicks EFM, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34(4):1220–2. http://www.ncbi.nlm.nih.gov/pubmed/12072321. Accessed 25 Aug 2018.PubMedCrossRefGoogle Scholar
  80. 80.
    Yi HJ, et al. Acute hyperammonemic encephalopathy after 5-fluorouracil based chemotherapy. Ann Surg Treat Res. 2016;90(3):179–82. http://www.ncbi.nlm.nih.gov/pubmed/26942162. Accessed 31 Aug 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Yokoe M, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):41–54. http://doi.wiley.com/10.1002/jhbp.515. Accessed 18 Sept 2018.PubMedCrossRefGoogle Scholar
  82. 82.
    Zhu LX, Geng XP, Fan ST. Spontaneous rupture of hepatocellular carcinoma and vascular injury. Arch Surg (Chicago, Ill: 1960). 2001;136(6):682–7. http://www.ncbi.nlm.nih.gov/pubmed/11387009. Accessed 17 Sept 2018.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Faisal S. Ali
    • 1
  • Hamzah Abu-Sbeih
    • 1
  • Emmanuel Coronel
    • 1
  • Yinghong Wang
    • 1
    Email author
  1. 1.The Department of Gastroenterology, Hepatology and NutritionThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations